View of THE EFFECT OF ERYTHROPOIETIN DOSE PHASE OF CORRECTION AS DRUG-RELATED PROBLEMS TO TARGET LEVEL OF HEMOGLOBIN IN REGULAR HEMODIALYSIS PATIENTS

Return to Article Details THE EFFECT OF ERYTHROPOIETIN DOSE PHASE OF CORRECTION AS DRUG-RELATED PROBLEMS TO TARGET LEVEL OF HEMOGLOBIN IN REGULAR HEMODIALYSIS PATIENTS Download Download PDF